Molecular risk stratification to direct therapy in endometrial cancer: ready for the clinic?

Affiliations

¹ Departments of Radiation Oncology Medical Centre, Leiden, The Netherlands. Electronic address: c.l.creutzberg@lumc.nl.
² Pathology, Leiden University Medical Centre, Leiden, The Netherlands.

Free article

Editorial

C L Creutzberg et al. Ann Oncol. 2018.

Free article

. 2018 May 1;29(5):1081-1082.

doi: 10.1093/annonc/mdy098.

¹ Departments of Radiation Oncology Medical Centre, Leiden, The Netherlands. Electronic address: c.l.creutzberg@lumc.nl.
² Pathology, Leiden University Medical Centre, Leiden, The Netherlands.

No abstract available

Comment on

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series.
Kommoss S, McConechy MK, Kommoss F, Leung S, Bunz A, Magrill J, Britton H, Kommoss F, Grevenkamp F, Karnezis A, Yang W, Lum A, Krämer B, Taran F, Staebler A, Lax S, Brucker SY, Huntsman DG, Gilks CB, McAlpine JN, Talhouk A. Kommoss S, et al. Ann Oncol. 2018 May 1;29(5):1180-1188. doi: 10.1093/annonc/mdy058. Ann Oncol. 2018. PMID: 29432521